OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Seizures and Epileptiform Activity in the Early Stages of Alzheimer Disease
Keith Vossel, Alexander J. Beagle, Gil D. Rabinovici, et al.
JAMA Neurology (2013) Vol. 70, Iss. 9, pp. 1158-1158
Open Access | Times Cited: 640
Keith Vossel, Alexander J. Beagle, Gil D. Rabinovici, et al.
JAMA Neurology (2013) Vol. 70, Iss. 9, pp. 1158-1158
Open Access | Times Cited: 640
Showing 1-25 of 640 citing articles:
Network abnormalities and interneuron dysfunction in Alzheimer disease
Jorge J. Palop, Lennart Mucke
Nature reviews. Neuroscience (2016) Vol. 17, Iss. 12, pp. 777-792
Open Access | Times Cited: 819
Jorge J. Palop, Lennart Mucke
Nature reviews. Neuroscience (2016) Vol. 17, Iss. 12, pp. 777-792
Open Access | Times Cited: 819
β-Hydroxybutyrate: A Signaling Metabolite
John C. Newman, Eric Verdin
Annual Review of Nutrition (2017) Vol. 37, Iss. 1, pp. 51-76
Open Access | Times Cited: 607
John C. Newman, Eric Verdin
Annual Review of Nutrition (2017) Vol. 37, Iss. 1, pp. 51-76
Open Access | Times Cited: 607
The road to restoring neural circuits for the treatment of Alzheimer's disease
Rebecca G. Canter, Jay Penney, Li‐Huei Tsai
Nature (2016) Vol. 539, Iss. 7628, pp. 187-196
Closed Access | Times Cited: 500
Rebecca G. Canter, Jay Penney, Li‐Huei Tsai
Nature (2016) Vol. 539, Iss. 7628, pp. 187-196
Closed Access | Times Cited: 500
A vicious cycle of β amyloid–dependent neuronal hyperactivation
Benedikt Zott, Manuel Simon, Wei Hong, et al.
Science (2019) Vol. 365, Iss. 6453, pp. 559-565
Open Access | Times Cited: 500
Benedikt Zott, Manuel Simon, Wei Hong, et al.
Science (2019) Vol. 365, Iss. 6453, pp. 559-565
Open Access | Times Cited: 500
Epileptic activity in Alzheimer's disease: causes and clinical relevance
Keith Vossel, Maria Carmela Tartaglia, Haakon B. Nygaard, et al.
The Lancet Neurology (2017) Vol. 16, Iss. 4, pp. 311-322
Open Access | Times Cited: 489
Keith Vossel, Maria Carmela Tartaglia, Haakon B. Nygaard, et al.
The Lancet Neurology (2017) Vol. 16, Iss. 4, pp. 311-322
Open Access | Times Cited: 489
A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome
Frances K. Wiseman, Tamara Al‐Janabi, John Hardy, et al.
Nature reviews. Neuroscience (2015) Vol. 16, Iss. 9, pp. 564-574
Open Access | Times Cited: 479
Frances K. Wiseman, Tamara Al‐Janabi, John Hardy, et al.
Nature reviews. Neuroscience (2015) Vol. 16, Iss. 9, pp. 564-574
Open Access | Times Cited: 479
Involvement of Astrocytes in Alzheimer’s Disease from a Neuroinflammatory and Oxidative Stress Perspective
Rodrigo E. González-Reyes, Mauricio O. Nava-Mesa, Karina Vargas-Sánchez, et al.
Frontiers in Molecular Neuroscience (2017) Vol. 10
Open Access | Times Cited: 453
Rodrigo E. González-Reyes, Mauricio O. Nava-Mesa, Karina Vargas-Sánchez, et al.
Frontiers in Molecular Neuroscience (2017) Vol. 10
Open Access | Times Cited: 453
Incidence and impact of subclinical epileptiform activity in Alzheimer's disease
Keith Vossel, Kamalini G. Ranasinghe, Alexander J. Beagle, et al.
Annals of Neurology (2016) Vol. 80, Iss. 6, pp. 858-870
Open Access | Times Cited: 447
Keith Vossel, Kamalini G. Ranasinghe, Alexander J. Beagle, et al.
Annals of Neurology (2016) Vol. 80, Iss. 6, pp. 858-870
Open Access | Times Cited: 447
Nicotinic ACh receptors as therapeutic targets in CNS disorders
Kelly T. Dineley, Anshul A. Pandya, Jerrel L. Yakel
Trends in Pharmacological Sciences (2015) Vol. 36, Iss. 2, pp. 96-108
Open Access | Times Cited: 418
Kelly T. Dineley, Anshul A. Pandya, Jerrel L. Yakel
Trends in Pharmacological Sciences (2015) Vol. 36, Iss. 2, pp. 96-108
Open Access | Times Cited: 418
Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer’s disease
Sérgio T. Ferreira, Mychael V. Lourenco, Maurício M. Oliveira, et al.
Frontiers in Cellular Neuroscience (2015) Vol. 9
Open Access | Times Cited: 311
Sérgio T. Ferreira, Mychael V. Lourenco, Maurício M. Oliveira, et al.
Frontiers in Cellular Neuroscience (2015) Vol. 9
Open Access | Times Cited: 311
Dendritic Structural Degeneration Is Functionally Linked to Cellular Hyperexcitability in a Mouse Model of Alzheimer’s Disease
Zuzana Šišková, Daniel Justus, Hiroshi Kaneko, et al.
Neuron (2014) Vol. 84, Iss. 5, pp. 1023-1033
Open Access | Times Cited: 293
Zuzana Šišková, Daniel Justus, Hiroshi Kaneko, et al.
Neuron (2014) Vol. 84, Iss. 5, pp. 1023-1033
Open Access | Times Cited: 293
Antisense Reduction of Tau in Adult Mice Protects against Seizures
Sarah L. DeVos, Dustin Kenneth Goncharoff, Guojun Chen, et al.
Journal of Neuroscience (2013) Vol. 33, Iss. 31, pp. 12887-12897
Open Access | Times Cited: 289
Sarah L. DeVos, Dustin Kenneth Goncharoff, Guojun Chen, et al.
Journal of Neuroscience (2013) Vol. 33, Iss. 31, pp. 12887-12897
Open Access | Times Cited: 289
Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals
Aaron P. Schultz, Jasmeer P. Chhatwal, Trey Hedden, et al.
Journal of Neuroscience (2017) Vol. 37, Iss. 16, pp. 4323-4331
Open Access | Times Cited: 285
Aaron P. Schultz, Jasmeer P. Chhatwal, Trey Hedden, et al.
Journal of Neuroscience (2017) Vol. 37, Iss. 16, pp. 4323-4331
Open Access | Times Cited: 285
Imbalance between firing homeostasis and synaptic plasticity drives early-phase Alzheimer’s disease
Boaz Styr, Inna Slutsky
Nature Neuroscience (2018) Vol. 21, Iss. 4, pp. 463-473
Open Access | Times Cited: 279
Boaz Styr, Inna Slutsky
Nature Neuroscience (2018) Vol. 21, Iss. 4, pp. 463-473
Open Access | Times Cited: 279
Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial
Petr Novák, Reinhold Schmidt, Eva Kontseková, et al.
The Lancet Neurology (2016) Vol. 16, Iss. 2, pp. 123-134
Closed Access | Times Cited: 270
Petr Novák, Reinhold Schmidt, Eva Kontseková, et al.
The Lancet Neurology (2016) Vol. 16, Iss. 2, pp. 123-134
Closed Access | Times Cited: 270
Epilepsy in older people
Arjune Sen, Nathalie Jetté, Masud Husain, et al.
The Lancet (2020) Vol. 395, Iss. 10225, pp. 735-748
Closed Access | Times Cited: 261
Arjune Sen, Nathalie Jetté, Masud Husain, et al.
The Lancet (2020) Vol. 395, Iss. 10225, pp. 735-748
Closed Access | Times Cited: 261
Cognition and dementia in older patients with epilepsy
Arjune Sen, Valentina Capelli, Masud Husain
Brain (2018) Vol. 141, Iss. 6, pp. 1592-1608
Open Access | Times Cited: 227
Arjune Sen, Valentina Capelli, Masud Husain
Brain (2018) Vol. 141, Iss. 6, pp. 1592-1608
Open Access | Times Cited: 227
Neuronal hyperactivity – A key defect in Alzheimer's disease?
Marc Aurel Busche, Arthur Konnerth
BioEssays (2015) Vol. 37, Iss. 6, pp. 624-632
Closed Access | Times Cited: 222
Marc Aurel Busche, Arthur Konnerth
BioEssays (2015) Vol. 37, Iss. 6, pp. 624-632
Closed Access | Times Cited: 222
Alzheimer’s Disease: From Firing Instability to Homeostasis Network Collapse
Samuel Frère, Inna Slutsky
Neuron (2018) Vol. 97, Iss. 1, pp. 32-58
Open Access | Times Cited: 222
Samuel Frère, Inna Slutsky
Neuron (2018) Vol. 97, Iss. 1, pp. 32-58
Open Access | Times Cited: 222
Modifiable Risk Factors for Alzheimer’s Disease
George A. Edwards, Nazaret Gamez, Gabriel Escobedo, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 221
George A. Edwards, Nazaret Gamez, Gabriel Escobedo, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 221
Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer’s disease: a systematic review
Danko Jeremic, Lydia Jiménez‐Díaz, Juan D. Navarro‐López
Ageing Research Reviews (2021) Vol. 72, pp. 101496-101496
Open Access | Times Cited: 220
Danko Jeremic, Lydia Jiménez‐Díaz, Juan D. Navarro‐López
Ageing Research Reviews (2021) Vol. 72, pp. 101496-101496
Open Access | Times Cited: 220
Blood-brain barrier dysfunction in aging induces hyperactivation of TGFβ signaling and chronic yet reversible neural dysfunction
Vladimir V. Senatorov, Aaron R. Friedman, Dan Z. Milikovsky, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 521
Closed Access | Times Cited: 207
Vladimir V. Senatorov, Aaron R. Friedman, Dan Z. Milikovsky, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 521
Closed Access | Times Cited: 207
Nav1.1-Overexpressing Interneuron Transplants Restore Brain Rhythms and Cognition in a Mouse Model of Alzheimer’s Disease
Magdalena Martínez‐Losa, Tara E. Tracy, Keran Ma, et al.
Neuron (2018) Vol. 98, Iss. 1, pp. 75-89.e5
Open Access | Times Cited: 205
Magdalena Martínez‐Losa, Tara E. Tracy, Keran Ma, et al.
Neuron (2018) Vol. 98, Iss. 1, pp. 75-89.e5
Open Access | Times Cited: 205
What electrophysiology tells us about Alzheimer's disease: a window into the synchronization and connectivity of brain neurons
Claudio Babiloni, Katarzyna J. Blinowska, Laura Bonanni, et al.
Neurobiology of Aging (2019) Vol. 85, pp. 58-73
Open Access | Times Cited: 202
Claudio Babiloni, Katarzyna J. Blinowska, Laura Bonanni, et al.
Neurobiology of Aging (2019) Vol. 85, pp. 58-73
Open Access | Times Cited: 202
Alzheimer’s disease brain-derived extracellular vesicles spread tau pathology in interneurons
Zhi Ruan, Dhruba Pathak, Srinidhi Venkatesan Kalavai, et al.
Brain (2020) Vol. 144, Iss. 1, pp. 288-309
Open Access | Times Cited: 198
Zhi Ruan, Dhruba Pathak, Srinidhi Venkatesan Kalavai, et al.
Brain (2020) Vol. 144, Iss. 1, pp. 288-309
Open Access | Times Cited: 198
